Delayed onset of rosiglitazone-induced pulmonary oedema

European Journal of Internal Medicine

Volumn 17, Issue 8, 2006, Pages 590-

  Fernando, Devaka J S ^a   Bulugahapitiya, Uditha ^a   Prior, Katherine ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Left ventricular failure; Metformin; Pulmonary oedema; Rosiglitazone; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; DIURETIC AGENT; GLICLAZIDE; METFORMIN PLUS ROSIGLITAZONE; ROSIGLITAZONE;

ADULT; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DIABETIC PATIENT; DRUG DOSE INCREASE; DRUG MEGADOSE; DYSPNEA; FEMALE; HUMAN; LETTER; LUNG EDEMA; NON INSULIN DEPENDENT DIABETES MELLITUS; RADIOGRAPHY; TREATMENT OUTCOME;

EID: 34248512954     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2006.05.004     Document Type: Letter

References (2)

1. Diamant M., and Heine R.J. Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence. Drugs 63 (2003) 1373-1405
2. Idris I., Gray S., and Donnelly R. Rosiglitazone and pulmonary oedema: an acute dose-dependent effect on human endothelial cell permeability. Diabetologia 46 2 (2003) 288-290